1-2 of 2
Keywords: Advanced non-small cell lung cancer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cryoablation Combined with Programmed Cell Death Protein 1 Inhibitor Pembrolizumab for Advanced Non-Small Cell Lung Cancer

Available to Purchase
Subject Area:
Further Areas , Oncology , Pharmacology
Li Wang, Kai Yang, Xinxin Xie, Hailiang Wei, Pengli Wang, Shaohui Wang
Journal: Chemotherapy
Chemotherapy (2025)
https://doi.org/10.1159/000545185
Published Online: 13 March 2025
...Li Wang; Kai Yang; Xinxin Xie; Hailiang Wei; Pengli Wang; Shaohui Wang Introduction: This study aims to evaluate the efficacy and safety of cryoablation combined with pembrolizumab treatment versus cryoablation alone in patients with advanced non-small cell lung cancer (NSCLC). Methods...
View articletitled, Cryoablation Combined with Programmed Cell Death Protein 1 Inhibitor Pembrolizumab for Advanced Non-Small Cell Lung Cancer
Open the PDF for Cryoablation Combined with Programmed Cell Death Protein 1 Inhibitor Pembrolizumab for Advanced Non-Small Cell Lung Cancer in another window
Journal Articles

The Value of Tumor Markers in Evaluating Chemotherapy Response and Prognosis in Chinese Patients with Advanced Non-Small Cell Lung Cancer

Available to Purchase
Subject Area:
Further Areas , Oncology , Pharmacology
Bo Jin, Ai-mi Huang, Run-bo Zhong, Bao-hui Han
Journal: Chemotherapy
Chemotherapy (2010) 56 (6): 417–423.
https://doi.org/10.1159/000317580
Published Online: 16 November 2010
...Bo Jin; Ai-mi Huang; Run-bo Zhong; Bao-hui Han Objective: The aim of this study was to assess the value of tumor markers in monitoring chemotherapy response and predicting prognosis in patients with advanced non-small cell lung cancer (NSCLC). Methods: We studied carcinoembryonic antigen (CEA...
View articletitled, The Value of Tumor Markers in Evaluating Chemotherapy Response and Prognosis in Chinese Patients with Advanced Non-Small Cell Lung Cancer
Open the PDF for The Value of Tumor Markers in Evaluating Chemotherapy Response and Prognosis in Chinese Patients with Advanced Non-Small Cell Lung Cancer in another window